324 related articles for article (PubMed ID: 25432535)
21. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
22. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.
Guo J; Tretiakova MS; Troxell ML; Osunkoya AO; Fadare O; Sangoi AR; Shen SS; Lopez-Beltran A; Mehra R; Heider A; Higgins JP; Harik LR; Leroy X; Gill AJ; Trpkov K; Campbell SC; Przybycin C; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2014 Nov; 38(11):1457-67. PubMed ID: 25093518
[TBL] [Abstract][Full Text] [Related]
24. Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex.
Pressey JG; Wright JM; Geller JI; Joseph DB; Pressey CS; Kelly DR
Pediatr Blood Cancer; 2010 Jul; 54(7):1035-7. PubMed ID: 20108343
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.
Parry L; Maynard JH; Patel A; Clifford SC; Morrissey C; Maher ER; Cheadle JP; Sampson JR
Br J Cancer; 2001 Oct; 85(8):1226-30. PubMed ID: 11710839
[TBL] [Abstract][Full Text] [Related]
26. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.
Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN
BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987
[TBL] [Abstract][Full Text] [Related]
27. Tuberous sclerosis complex: tumors and tumorigenesis.
Borkowska J; Schwartz RA; Kotulska K; Jozwiak S
Int J Dermatol; 2011 Jan; 50(1):13-20. PubMed ID: 21182496
[TBL] [Abstract][Full Text] [Related]
28. Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (TSC).
Machacek ME; Wu CL; Cornejo KM
Semin Diagn Pathol; 2024 Jan; 41(1):8-19. PubMed ID: 37993384
[TBL] [Abstract][Full Text] [Related]
29. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
31. Novel TSC1 and TSC2 gene mutations in Chinese patients with tuberous sclerosis complex.
Yu T; He Y; Li N; Zhou Y; Wang Z; Fu Q; Wang J; Wang J
Clin Neurol Neurosurg; 2017 Mar; 154():104-108. PubMed ID: 28178598
[TBL] [Abstract][Full Text] [Related]
32. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
[TBL] [Abstract][Full Text] [Related]
33. [Tests for loss of heterozygosity in tuberous sclerosis].
Jóźwiak S; Dabora S; Kasprzyk-Obara J; Domańska-Pakieła D; Grajkowska W
Przegl Lek; 2001; 58 Suppl 1():12-5. PubMed ID: 11355103
[TBL] [Abstract][Full Text] [Related]
34. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation.
Rok P; Kasprzyk-Obara J; Domańska-Pakieła D; Jóźwiak S
Med Sci Monit; 2005 May; 11(5):CR230-234. PubMed ID: 15874888
[TBL] [Abstract][Full Text] [Related]
35. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked?
Henske EP
Curr Mol Med; 2004 Dec; 4(8):825-31. PubMed ID: 15579029
[TBL] [Abstract][Full Text] [Related]
36. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
Chu-Shore CJ; Major P; Montenegro M; Thiele E
Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
[TBL] [Abstract][Full Text] [Related]
37. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified.
Camposano SE; Greenberg E; Kwiatkowski DJ; Thiele EA
Ann Hum Genet; 2009 Mar; 73(2):141-6. PubMed ID: 19133941
[TBL] [Abstract][Full Text] [Related]
38. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
[TBL] [Abstract][Full Text] [Related]
39. Two different types of infantile renal cell carcinomas associated with tuberous sclerosis.
Kubo M; Iwashita K; Oyachi N; Oyama T; Yamamoto T
J Pediatr Surg; 2011 Oct; 46(10):E37-41. PubMed ID: 22008361
[TBL] [Abstract][Full Text] [Related]
40. Quick genetic screening using targeted next-generation sequencing in patients with tuberous sclerosis.
Liu Q; Huang Y; Zhang M; Wang LQ; Guo XN; Si N; Qi Z; Zhou XQ; Cui LY
J Child Neurol; 2015 Apr; 30(5):610-4. PubMed ID: 24789117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
